Zobrazeno 1 - 10
of 1 810
pro vyhledávání: '"acquired hemophilia a"'
Autor:
Antonella Mameli, Francesco Marongiu, Lara Fenu, Maria Filomena Ruberto, Paola Schirru, Simona Cornacchini, Doris Barcellona
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 4, Pp 264-270 (2024)
Objective: Acquired hemophilia A (AHA) is a rare autoimmune disease characterized by the presence of autoantibodies against coagulation factor VIII, leading to spontaneous hemorrhage in patients without a prior family or personal history of bleeding.
Externí odkaz:
https://doaj.org/article/fe00f85d315749bba143e542877ea762
Autor:
Ma'in Abumuhfouz, Anas Al-sadi, Awni Alshurafa, Israa Jawarneh, Ruba Y. Taha, Sarah A. Elkourashy
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Objectives Acquired hemophilia A (AHA) is a rare autoimmune disorder that presents with spontaneous bleeding due to the development of autoantibodies against coagulation factor VIII. This study aims to highlight the challenges in diagnosing and treat
Externí odkaz:
https://doaj.org/article/63368a0c18ec471bb86726ea02a11344
Autor:
Nikolaos Evangelidis, Nikolaos Kotsiou, Paschalis Evangelidis, Vlasios I. Alevizopoulos, Iasonas Dermitzakis, Sofia Chissan, Sofia Vakalopoulou, Eleni Gavriilaki
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 6, Pp 5147-5160 (2024)
Acquired hemophilia A (AHA) is a bleeding disorder characterized by the immunological inhibition of factor VIII (FVIII) of the hemostatic pathway leading to hemorrhagic events. Different domains of FVIII are the target of autoantibodies (mainly immun
Externí odkaz:
https://doaj.org/article/112a622ed36343b2a37ed966a78b09ec
Autor:
Oubai Nayouf, Miriam Laflouf, Ibrahim Hamdan, Ibrahim Alghazawi, Omar Aldairi, Ameen Sulaiman
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key clinical message Acquired hemophilia A is a rare bleeding disorder. Rapid diagnosis with prolonged aPTT and low FVIII, and immediate use of bypassing agents and steroids are crucial for better outcomes, highlighting the importance of early recogn
Externí odkaz:
https://doaj.org/article/33cb5ca4db8c433280ebb66bcb25f0de
Autor:
Andrea Ceglédi, Árpád Bátai, János Dolgos, Mónika Fekete, László Gopcsa, Viktória Király, Gergely Lakatos, György Nagy, Zsuzsanna Szemlaky, Andrea Várkonyi, Beáta Vilimi, Gábor Mikala, Imre Bodó
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
IntroductionAcquired Hemophilia A (AHA) is a rare autoimmune disorder characterized by the emergence of inhibitors that specifically target coagulation Factor VIII, frequently resulting in severe bleeding episodes.MethodsWe conducted a retrospective
Externí odkaz:
https://doaj.org/article/f43d9bfbb18044cebdc9ea01646dc51e
Autor:
Vittoria Gammaldi, Anna Guida, Carolina Bologna, Antonietta De Sena, Marina Lugarà, Claudio De Luca, Fabio Granato Corigliano, Mariavittoria Guerra, Gabriella Oliva, Luca Mocerino, Aquilino Flavio Zarrella, Maria Gabriella Coppola, Vincenzo Nuzzo, Paolo Tirelli, Pasquale Madonna
Publikováno v:
Italian Journal of Medicine, Vol 18, Iss 2 (2024)
The rare hemorrhagic disorder known as acquired hemophilia A (AHA) is brought on by the spontaneous development of autoantibodies against coagulation factor VIII (FVIII). It may be secondary to autoimmune diseases or cancers, or it may be idiopathic.
Externí odkaz:
https://doaj.org/article/74ec7dee27b84f0bbe4f30a27d8a2ed9
Autor:
Masahiro Ieko, Kazumasa Ohmura, Sumiyoshi Naito, Mika Yoshida, Hisaomi Sasaki, Tsuyoshi Sato, Norifumi Sugawara, Nobuhiko Takahashi, Akitada Ichinose
Publikováno v:
Exploration of Immunology, Vol 3, Iss 4, Pp 286-299 (2023)
In patients with autoimmune coagulation factor deficiency (AiCFD), the production of autoantibodies that inhibit coagulation factors in the blood reduces the activity of those relevant coagulation factors, resulting in severe bleeding symptoms. Recen
Externí odkaz:
https://doaj.org/article/48b2cbefa8b641c79e5ce162032deb0f
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 197-201 (2023)
This survey study aimed to evaluate the level of awareness and knowledge of acquired hemophilia A (AHA) among physicians from various specialties. Data were collected by administering a questionnaire containing questions about two patient profiles to
Externí odkaz:
https://doaj.org/article/79ba391e605943bb878b3a9e19008a9f
Autor:
Chanakarn Kanitthamniyom, Pharit Siladech, Natchaya Polpichai, Maireigh McCullough, Sakditad Saowapa
Publikováno v:
Clinical Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
Key Clinical Message Acquired hemophilia A (AHA) can present as life‐threatening bleeding during the postpartum period. Prompt treatment allows patients with AHA to achieve complete remission and have normal subsequent pregnancies. Abstract Acquire
Externí odkaz:
https://doaj.org/article/a8e8e0ab3bb544129ff350f139090516
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 532-543 (2023)
Abstract Vaccination against SARS‐CoV2 has been the largest vaccination campaign over the past two decades. The aim of this study is to qualitatively assess the reported cases of acquired hemophilia A (AHA) that developed after COVID‐19 vaccinati
Externí odkaz:
https://doaj.org/article/22df74f90cd240b1a8d1dd6c210daad9